ReviewJournal of diabetes science and technology2019
Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age.
Review in Journal of diabetes science and technology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 47 citations in OpenAlex.
- Patient-specific deep offline artificial pancreas for blood glucose regulation in type 1 diabetes.Smart health (Amsterdam, Netherlands) · 2026Article
- Wireless, Programmable, and Refillable Hydrogel Bioelectronics for Enhanced Diabetic Wound Healing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Article
- Impact of a tubeless, disposable insulin pump on emergency department visits and inpatient admissions among a Medicare population.Journal of managed care & specialty pharmacy · 2024Observational
- Individualized selection of recent glucose monitoring devices for self-management based on competitive features.Pakistan journal of medical sciences · 2024Review
- Development and validation of a distress measurement for insulin injections among patients with diabetes.Scientific reports · 2023Article
- Patch Pumps: Periodic Insulin Delivery Patterns.Journal of diabetes science and technology · 2023Article
- Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management System.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2023Article
- Evaluation of the Accuracy and Reliability of a Tubeless Insulin Infusion System Under Laboratory Conditions.Journal of diabetes science and technology · 2022Article
- Intelligent automated drug administration and therapy: future of healthcare.Drug delivery and translational research · 2021Review
- Phenolic Preservative Removal from Commercial Insulin Formulations Reduces Tissue Inflammation while Maintaining Euglycemia.ACS pharmacology & translational science · 2021Article
- First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes.Diabetes technology & therapeutics · 2021Article
- Diabetology 4.0: Scoping Review of Novel Insights and Possibilities Offered by Digitalization.Journal of medical Internet research · 2021Article
- A New Wearable System for Home Sleep Apnea Testing, Screening, and Classification.Sensors (Basel, Switzerland) · 2020Article
- Review of the OmnipodTherapeutic delivery · 2020Review
- Advances in Type 1 Diabetes Technology Over the Last Decade.European endocrinology · 2019Review
- A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy.Diabetes spectrum : a publication of the American Diabetes Association · 2019Article
- Insulin Pumping Patches: Emerging Insulin Delivery Systems.Journal of diabetes science and technology · 2019Article
- Novel Bluetooth-Enabled Tubeless Insulin Pump: A User Experience Design Approach for a Connected Digital Diabetes Management Platform.Journal of diabetes science and technology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Omnipod DASH™ Insulin Management System (Insulet Corp, Billerica, MA) is a discreet, tubeless, wearable insulin pump that holds up to 200 units of U-100 insulin and delivers therapy through customizable basal rates and bolus amounts. This recently FDA-cleared system consists of the insulin pump ("Pod"), which is worn on body and delivers insulin, and the Personal Diabetes Manager (PDM), which is a handheld device used to wirelessly control and monitor the Pod functionality. The PDM can also be paired with the CONTOUR
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.